These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 20861918)
1. Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia. Jabbour E; Deininger M; Hochhaus A Leukemia; 2011 Feb; 25(2):201-10. PubMed ID: 20861918 [TBL] [Abstract][Full Text] [Related]
2. Treatment-, patient-, and disease-related factors and the emergence of adverse events with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. Irvine E; Williams C Pharmacotherapy; 2013 Aug; 33(8):868-81. PubMed ID: 23553655 [TBL] [Abstract][Full Text] [Related]
3. Practical management of toxicities associated with tyrosine kinase inhibitors in chronic myeloid leukemia. Quintás-Cardama A; Cortés JE; Kantarjian H Clin Lymphoma Myeloma; 2008 Mar; 8 Suppl 3():S82-8. PubMed ID: 19254885 [TBL] [Abstract][Full Text] [Related]